1. Электронный научный архив УрФУ
  2. 00. Общеуниверситетские коллекции
  3. Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC
Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/90517
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMeyer, C.en
dc.contributor.authorLopes, B. A.en
dc.contributor.authorCaye-Eude, A.en
dc.contributor.authorCavé, H.en
dc.contributor.authorArfeuille, C.en
dc.contributor.authorCuccuini, W.en
dc.contributor.authorSutton, R.en
dc.contributor.authorVenn, N. C.en
dc.contributor.authorOh, S. H.en
dc.contributor.authorTsaur, G.en
dc.contributor.authorEscherich, G.en
dc.contributor.authorFeuchtinger, T.en
dc.contributor.authorKosasih, H. J.en
dc.contributor.authorKhaw, S. L.en
dc.contributor.authorEkert, P. G.en
dc.contributor.authorPombo-de-Oliveira, M. S.en
dc.contributor.authorBidet, A.en
dc.contributor.authorDjahanschiri, B.en
dc.contributor.authorEbersberger, I.en
dc.contributor.authorZaliova, M.en
dc.contributor.authorZuna, J.en
dc.contributor.authorZermanova, Z.en
dc.contributor.authorJuvonen, V.en
dc.contributor.authorGrümayer, R. P.en
dc.contributor.authorFazio, G.en
dc.contributor.authorCazzaniga, G.en
dc.contributor.authorLarghero, P.en
dc.contributor.authorEmerenciano, M.en
dc.contributor.authorMarschalek, R.en
dc.date.accessioned2020-09-29T09:47:39Z-
dc.date.available2020-09-29T09:47:39Z-
dc.date.issued2019-
dc.identifier.citationHuman MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions / C. Meyer, B. A. Lopes, A. Caye-Eude, H. Cavé, et al. . — DOI 10.1038/s41375-019-0451-7 // Leukemia. — 2019. — Vol. 9. — Iss. 33. — P. 2306-2340.en
dc.identifier.issn0887-6924-
dc.identifier.otherhttps://www.nature.com/articles/s41375-019-0451-7.pdfpdf
dc.identifier.other1good_DOI
dc.identifier.other0aba77f4-4be5-4dfd-b866-960eb78f6b71pure_uuid
dc.identifier.otherhttp://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=85063349147m
dc.identifier.urihttp://elar.urfu.ru/handle/10995/90517-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq: PQ-2017#305529/2017-0en
dc.description.sponsorshipDeutsche Forschungsgemeinschaft, DFG: MA 1876/12-1en
dc.description.sponsorshipAlexander von Humboldt-Stiftung: 88881.136091/2017-01en
dc.description.sponsorshipRVO-VFN64165, 26/203.214/2017en
dc.description.sponsorship2018.070.1en
dc.description.sponsorshipAssociazione Italiana per la Ricerca sul Cancro, AIRC: IG2015, 17593en
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPESen
dc.description.sponsorshipCancer Australia: PdCCRS1128727en
dc.description.sponsorshipCancerfondenen
dc.description.sponsorshipBarncancerfondenen
dc.description.sponsorshipVetenskapsrÃ¥det, VRen
dc.description.sponsorshipCrafoordska Stiftelsenen
dc.description.sponsorshipKnut och Alice Wallenbergs Stiftelseen
dc.description.sponsorshipLund University Medical Faculty Foundationen
dc.description.sponsorshipXiamen University, XMUen
dc.description.sponsorship2014S06en
dc.description.sponsorship17-74-30019en
dc.description.sponsorshipC7838/A15733en
dc.description.sponsorshipSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF: 31003A_140913en
dc.description.sponsorshipCNIBen
dc.description.sponsorshipInstitut National Du Cancer, INCaen
dc.description.sponsorshipR01 NCI CA167824en
dc.description.sponsorshipNational Institutes of Health, NIH: S10OD018522en
dc.description.sponsorship2016/2017, 02R/2016en
dc.description.sponsorshipAU 525/1-1en
dc.description.sponsorshipDeutschen Konsortium für Translationale Krebsforschung, DKTKen
dc.description.sponsorship70112951en
dc.description.sponsorshipSmithsonian Institution, SIen
dc.description.sponsorshipIsrael Science Foundation, ISFen
dc.description.sponsorshipAustrian Science Fund, FWF: W1212en
dc.description.sponsorshipSFB-F06107, SFB-F06105en
dc.description.sponsorshipAcknowledgements BAL received a fellowship provided by CAPES and the Alexander von Humboldt Foundation (#88881.136091/2017-01). ME is supported by CNPq (PQ-2017#305529/2017-0) and FAPERJ-JCNE (#26/203.214/2017) research scholarships, and ZZ by grant RVO-VFN64165. GC is supported by the AIRC Investigator grant IG2015 grant no. 17593 and RS by Cancer Australia grant PdCCRS1128727. This work was supported by grants to RM from the “Georg und Franziska Speyer’sche Hochsschulstiftung”, the “Wilhelm Sander foundation” (grant 2018.070.1) and DFG grant MA 1876/12-1.en
dc.description.sponsorshipAcknowledgements This work was supported by The Swedish Childhood Cancer Foundation, The Swedish Cancer Society, The Swedish Research Council, The Knut and Alice Wallenberg Foundation, BioCARE, The Crafoord Foundation, The Per-Eric and Ulla Schyberg Foundation, The Nilsson-Ehle Donations, The Wiberg Foundation, and Governmental Funding of Clinical Research within the National Health Service. Work performed at the Center for Translational Genomics, Lund University has been funded by Medical Faculty Lund University, Region Skåne and Science for Life Laboratory, Sweden.en
dc.description.sponsorshipAcknowledgements This work was supported by the Fujian Provincial Natural Science Foundation 2016S016 China and Putian city Natural Science Foundation 2014S06(2), Fujian Province, China. Alexey Ste-panov and Alexander Gabibov were supported by Russian Scientific Foundation project No. 17-74-30019. Jinqi Huang was supported by a doctoral fellowship from Xiamen University, China.en
dc.description.sponsorshipAcknowledgments This work was supported by the Swiss National Science Foundation (grant 31003A_140913; OH) and the Cancer Research UK Experimental Cancer Medicine Centre Network, Cardiff ECMCI, grant C7838/A15733. We thank N. Carpino for the Sts-1/2 double-KO mice.en
dc.description.sponsorshipAcknowledgements This work was supported by the French National Cancer Institute (INCA) and the Fondation Française pour la Recherche contre le Myélome et les Gammapathies (FFMRG), the Intergroupe Francophone du Myélome (IFM), NCI R01 NCI CA167824 and a generous donation from Matthew Bell. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD018522. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the Association des Malades du Myélome Multiple (AF3M) for their continued support and participation. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization.en
dc.description.sponsorshipWe are indebted to all members of our groups for useful discussions and for their critical reading of the manuscript. Special thanks go to Silke Furlan, Friederike Opitz and Bianca Killing. F.A. is supported by the Deutsche For-schungsgemeinschaft (DFG, AU 525/1-1). J.H. has been supported by the German Children’s Cancer Foundation (Translational Oncology Program 70112951), the German Carreras Foundation (DJCLS 02R/2016), Kinderkrebsstiftung (2016/2017) and ERA PerMed GEPARD. Support by Israel Science Foundation, ERA-NET and Science Ministry (SI). A. B. is supported by the German Consortium of Translational Cancer Research, DKTK. We are grateful to the Jülich Supercomputing Centre at the Forschungszemtrum Jülich for granting computing time on the supercomputer JURECA (NIC project ID HKF7) and to the “Zentrum für Informations-und Medientechnologie” (ZIM) at the Heinrich Heine University Düsseldorf for providing computational support to H. G. The study was performed in the framework of COST action CA16223 “LEGEND”.en
dc.description.sponsorshipFunding The work was supported by the Austrian Science Fund FWF grant SFB-F06105 to RM and SFB-F06107 to VS and FWF grant W1212 to VS.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherNature Publishing Groupen
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.rightscc-byother
dc.sourceLeukemiaen
dc.subjectAF10 GENEen
dc.subjectAF4 GENEen
dc.subjectAF6 GENEen
dc.subjectAF9 GENEen
dc.subjectBREAKPOINT CLUSTER REGIONen
dc.subjectCANCER PATIENTen
dc.subjectCENTROMEREen
dc.subjectCHROMOSOME 11en
dc.subjectCHROMOSOME REARRANGEMENTen
dc.subjectCHROMOSOME TRANSLOCATIONen
dc.subjectCOHORT ANALYSISen
dc.subjectELL GENEen
dc.subjectENL GENEen
dc.subjectEPS15 GENEen
dc.subjectEXONen
dc.subjectGENEen
dc.subjectGENE CLUSTERen
dc.subjectGENE DELETIONen
dc.subjectGENE FUSIONen
dc.subjectGENE IDENTIFICATIONen
dc.subjectGENE LOCATIONen
dc.subjectGENETIC ASSOCIATIONen
dc.subjectGENETIC TRANSCRIPTIONen
dc.subjectHUMANen
dc.subjectINTRONen
dc.subjectKMT2A GENEen
dc.subjectLETTERen
dc.subjectLEUKEMIAen
dc.subjectMLL GENEen
dc.subjectPOLYMERASE CHAIN REACTIONen
dc.subjectPRIORITY JOURNALen
dc.subjectPTD GENEen
dc.subjectUSP2 GENEen
dc.subjectGENE TRANSLOCATIONen
dc.subjectGENETICSen
dc.subjectFUSION PROTEINen
dc.subjectHISTONE LYSINE METHYLTRANSFERASEen
dc.subjectKMT2A PROTEIN, HUMANen
dc.subjectMIXED LINEAGE LEUKEMIA PROTEINen
dc.subjectUBIQUITIN THIOLESTERASEen
dc.subjectUSP2 PROTEIN, HUMANen
dc.subjectCOHORT STUDIESen
dc.subjectHISTONE-LYSINE N-METHYLTRANSFERASEen
dc.subjectHUMANSen
dc.subjectLEUKEMIAen
dc.subjectMYELOID-LYMPHOID LEUKEMIA PROTEINen
dc.subjectRECOMBINANT FUSION PROTEINSen
dc.subjectTRANSLOCATION, GENETICen
dc.subjectUBIQUITIN THIOLESTERASEen
dc.titleHuman MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusionsen
dc.typeLetteren
dc.typeinfo:eu-repo/semantics/otheren
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.doi10.1038/s41375-019-0451-7-
dc.identifier.scopus85063349147-
local.affiliationDCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germanyen
local.affiliationDivision of Clinical Research, Research Center, Instituto Nacional de Cancer, Rio de Janeiro, Brazilen
local.affiliationDepartment of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, Franceen
local.affiliationDepartment of Cytogenetics, Saint Louis Hospital, Paris, Franceen
local.affiliationChildren’s Cancer Institute Australia, University of NSW Sydney, Sydney, Australiaen
local.affiliationDepartment of Laboratory Medicine, Inje University College of Medicine, Busan, South Koreaen
local.affiliationRegional Children Hospital 1, Research Institute of Medical Cell Technologies, Pediatric Oncology and Hematology Center, Ural Federal University named after the first President of Russia BN Yeltsin, Ekaterinburg, Russian Federationen
local.affiliationClinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germanyen
local.affiliationDepartment of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner University Children’s Hospital, Ludwig Maximilian University Munich, Munich, Germanyen
local.affiliationMurdoch Children’s Research Institute, The Royal Children’s Hospital, Flemington Road Parkville, Victoria, 3052, Australiaen
local.affiliationPediatric Hematology-Oncology Program—Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazilen
local.affiliationLaboratoire d’Hématologie, University Hospital, Brest, CHU de Bordeaux, Bordeaux, Franceen
local.affiliationDepartment of Applied Bioinformatics, Institute of Cell Biology and Neuroscience, Goethe-Universität Frankfurt, Frankfurt am Main, 60438, Germanyen
local.affiliationSenckenberg Climate and Research Centre (BIK-F), Frankfurt am Main, 60325, Germanyen
local.affiliationCLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republicen
local.affiliationCenter of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republicen
local.affiliationDepartment of Clinical Chemistry and Laboratory Division, Turku University Hospital, Turku, Finlanden
local.affiliationChildren’s Cancer Research Institute, Medical University of Vienna, Vienna, Austriaen
local.affiliationCentro Ricerca Tettamanti, Clinica Pediatrica University of Milano-Bicocca, Monza, Italyen
local.contributor.employeeMeyer, C., DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germanyru
local.contributor.employeeLopes, B.A., DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germany, Division of Clinical Research, Research Center, Instituto Nacional de Cancer, Rio de Janeiro, Brazilru
local.contributor.employeeCaye-Eude, A., Department of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, Franceru
local.contributor.employeeCavé, H., Department of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, Franceru
local.contributor.employeeArfeuille, C., Department of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, Franceru
local.contributor.employeeCuccuini, W., Department of Cytogenetics, Saint Louis Hospital, Paris, Franceru
local.contributor.employeeSutton, R., Children’s Cancer Institute Australia, University of NSW Sydney, Sydney, Australiaru
local.contributor.employeeVenn, N.C., Children’s Cancer Institute Australia, University of NSW Sydney, Sydney, Australiaru
local.contributor.employeeOh, S.H., DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germany, Department of Laboratory Medicine, Inje University College of Medicine, Busan, South Korearu
local.contributor.employeeTsaur, G., Regional Children Hospital 1, Research Institute of Medical Cell Technologies, Pediatric Oncology and Hematology Center, Ural Federal University named after the first President of Russia BN Yeltsin, Ekaterinburg, Russian Federationru
local.contributor.employeeEscherich, G., Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germanyru
local.contributor.employeeFeuchtinger, T., Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner University Children’s Hospital, Ludwig Maximilian University Munich, Munich, Germanyru
local.contributor.employeeKosasih, H.J., Murdoch Children’s Research Institute, The Royal Children’s Hospital, Flemington Road Parkville, Victoria, 3052, Australiaru
local.contributor.employeeKhaw, S.L., Murdoch Children’s Research Institute, The Royal Children’s Hospital, Flemington Road Parkville, Victoria, 3052, Australiaru
local.contributor.employeeEkert, P.G., Children’s Cancer Institute Australia, University of NSW Sydney, Sydney, Australia, Murdoch Children’s Research Institute, The Royal Children’s Hospital, Flemington Road Parkville, Victoria, 3052, Australiaru
local.contributor.employeePombo-de-Oliveira, M.S., Pediatric Hematology-Oncology Program—Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazilru
local.contributor.employeeBidet, A., Laboratoire d’Hématologie, University Hospital, Brest, CHU de Bordeaux, Bordeaux, Franceru
local.contributor.employeeDjahanschiri, B., Department of Applied Bioinformatics, Institute of Cell Biology and Neuroscience, Goethe-Universität Frankfurt, Frankfurt am Main, 60438, Germanyru
local.contributor.employeeEbersberger, I., Department of Applied Bioinformatics, Institute of Cell Biology and Neuroscience, Goethe-Universität Frankfurt, Frankfurt am Main, 60438, Germany, Senckenberg Climate and Research Centre (BIK-F), Frankfurt am Main, 60325, Germanyru
local.contributor.employeeZaliova, M., CLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republicru
local.contributor.employeeZuna, J., CLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republicru
local.contributor.employeeZermanova, Z., Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republicru
local.contributor.employeeJuvonen, V., Department of Clinical Chemistry and Laboratory Division, Turku University Hospital, Turku, Finlandru
local.contributor.employeeGrümayer, R.P., Children’s Cancer Research Institute, Medical University of Vienna, Vienna, Austriaru
local.contributor.employeeFazio, G., Centro Ricerca Tettamanti, Clinica Pediatrica University of Milano-Bicocca, Monza, Italyru
local.contributor.employeeCazzaniga, G., Centro Ricerca Tettamanti, Clinica Pediatrica University of Milano-Bicocca, Monza, Italyru
local.contributor.employeeLarghero, P., DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germanyru
local.contributor.employeeEmerenciano, M., Division of Clinical Research, Research Center, Instituto Nacional de Cancer, Rio de Janeiro, Brazilru
local.contributor.employeeMarschalek, R., DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germanyru
local.description.firstpage2306-
local.description.lastpage2340-
local.issue33-
local.volume9-
dc.identifier.wos000484399300014-
local.identifier.pure10773870-
local.identifier.eid2-s2.0-85063349147-
local.identifier.wosWOS:000484399300014-
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
10.1038-s41375-019-0451-7.pdf7,45 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.